Salivary biomarkers and their efficacies as diagnostic tools for Oral Squamous Cell Carcinoma : systematic review and meta-analysis

dc.centroUniversidad Cardenal Herrera-CEU
dc.contributor.authorGaba, Fariah
dc.contributor.authorSheth Shah, Chirag Chandrakant
dc.contributor.authorVeses Jiménez, Verónica
dc.contributor.otherUCH. Departamento de Ciencias Biomédicas
dc.contributor.otherUCH. Departamento de Medicina (Extinguido)
dc.contributor.otherProducción Científica UCH 2021
dc.contributor.otherUCH. Departamento de Medicina y Cirugía
dc.date2021
dc.date.accessioned2019-09-27T04:00:11Z
dc.date.available2019-09-27T04:00:11Z
dc.date.issued2021-03-19
dc.descriptionEsta es la versión pre-print del artículo, el cual se encuentra disponible en la siguiente URL: https://onlinelibrary.wiley.com/doi/full/10.1111/jop.12791
dc.description.abstractMore than 90% of malignant tumors of the head and neck are oral squamous cell carcinomas (OSCC). Early OSCC detection using salivary biomarkers could prevent malignant transformations and enhance patient survival. A systematic search in MEDLINE and the Central Register of Controlled Trials and meta-analysis were undertaken to identify the screening potential of 6 salivary biomarkers for early OSCC detection: IL-8, IL1-β, DUSP-1 and S100P mRNAs, miR125a and miR200a microRNAs. The sensitivities of IL-8 (0.41; 95%CI 0.19-0.99), IL1-β (0.26; 95%CI 0.19- 0.99), DUSP-1 (0.61; 95%CI 0.01-0.98), and S100P (0.67; 95%CI 0.32- 0.99) were calculated. Specificities of the biomarkers analyzed were found to be IL-8 (0.69; 95%CI 0.66-0.99), IL1-β (0.47; 95%CI 0.46 - 0.90), DUSP-1 (0.75; 95%CI 0.33-1) and S100P (0.73; 95%CI 0.18-0.99). Early detection of OSCC was best achieved by screening for salivary mRNA DUSP-1 and S100P. Further investigation is required into miRNAs as novel biomarkers
dc.formatapplication/pdf
dc.identifier.citationGaba, FI., Sheth, CC. & Veses, V. (2021). Salivary biomarkers and their efficacies as diagnostic tools for Oral Squamous Cell Carcinoma : systematic review and meta-analysis. Journal of Oral Pathology and Medicine, vol. 50, i. 3 (mar.), pp. 299-307. DOI: https://doi.org/10.1111/jop.12791
dc.identifier.doihttps://doi.org/10.1111/jop.12791
dc.identifier.issn0904-2512
dc.identifier.issn1600-0714 (Electrónico)
dc.identifier.urihttp://hdl.handle.net/10637/10614
dc.language.isoes
dc.language.isoen
dc.publisherJohn Wiley & Sons.
dc.relation.ispartofJournal of Oral Pathology and Medicine (mar. 2021).
dc.rightsopen access
dc.rights.cchttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subjectSaliva - Análisis.
dc.subjectMarcadores tumorales.
dc.subjectCancer cells.
dc.subjectCélulas cancerosas.
dc.subjectSaliva - Analysis.
dc.subjectBoca - Cáncer.
dc.subjectMouth - Cancer.
dc.subjectTumor markers.
dc.titleSalivary biomarkers and their efficacies as diagnostic tools for Oral Squamous Cell Carcinoma : systematic review and meta-analysis
dc.typeArtículo
dspace.entity.typePublicationes
relation.isAuthorOfPublication8d0b353f-814b-4c35-acf1-72f63213467c
relation.isAuthorOfPublication96812722-e6c4-4b69-9a37-9f16cde71444
relation.isAuthorOfPublication.latestForDiscovery8d0b353f-814b-4c35-acf1-72f63213467c

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Salivary_Gaba_JOOPAM_2021.pdf
Size:
616.21 KB
Format:
Adobe Portable Document Format